Companies sponsors |
Sanofi |
Others |
Department of Health and Social Care |
|
Health Technology Wales (HTW) |
|
NHS England |
Patient carer groups |
Myeloma UK |
Professional groups |
Association of Cancer Physicians |
|
Cancer Research UK |
|
Royal College of Physicians |
|
Royal College of Radiologists |
|
UK Myeloma Society |
Associated public health groups |
None |
Comparator companies |
J&J Innovative Medicine (bortezomib, daratumumab) (confidentiality agreement signed, participating) |
|
Accord Healthcare (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Advanz Pharma (dexamethasone, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Amarox (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Aspen (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Aspire Pharma (bortezomib, dexamethasone) (confidentiality agreement not signed, not participating) |
|
Aurobindo Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
|
Baxter Healthcare (cyclophosphamide) (confidentiality agreement not signed, not participating) |
|
Biocon Pharma (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Biotech Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
|
Bristol-Myers Squibb (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Dr Reddy’s Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Fresenius Kabi (bortezomib) (confidentiality agreement not signed, not participating) |
|
Hameln Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Glenmark Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Hospira (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Kent Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
|
Krka UK (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Martindale Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Medac gmBH (bortezomib) (confidentiality agreement not signed, not participating) |
|
MSN Laboratories Europe (bortezomib) (confidentiality agreement not signed, not participating) |
|
Mylan (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Pfizer (bortezomib) (confidentiality agreement not signed, not participating) |
|
Piramal Critical Care (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Rosemont Pharmaceuticals (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Sandoz (bortezomib, cyclophosphamide) (confidentiality agreement not signed, not participating) |
|
Sun Pharmaceuticals (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Synchrony Pharma (dexamethasone) (confidentiality agreement not signed, not participating) |
|
Teva UK (dexamethasone, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Thornton & Ross (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Tillomed Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
|
Torrent Pharma (lenalidomide) (confidentiality agreement not signed, not participating) |
|
Viatris UK Healthcare (bortezomib, lenalidomide) (confidentiality agreement not signed, not participating) |
|
Zentiva (lenalidomide) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health - Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Institute of Cancer Research |